Pillstats
Rx only · Granule, Delayed Release · Oral

Pantoprazole Sodium

Brands: Protonix Delayed-Release · Pantoprazole Sodium

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)40790
US makers6 labelers
Packages6
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.78$3.55$5.33$7.10Dec 2025Mar 2026Jul 2026
$6.177
Latest avg · Jul 22, 2026
+48%
Since Dec 17, 2025
6
Active US suppliers
33%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.4K4.9K7.3K9.7K2025 Q12025 Q22025 Q32025 Q42026 Q1
8.3K
Rx · 2026 Q1
273K
Units dispensed
+9%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
NorthStar RxLLCunknown1SUPPLYING
Edenbridge Pharmaceuticals LLC.unknown1SUPPLYING
Aurobindo Pharma Limitedunknown1SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown1SUPPLYING
Camber Pharmaceuticals, Inc.unknown1SUPPLYING
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.unknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jul 25, 2022
    RECALLRecall (Class II): Pantoprazole Sodium for Delayed-Release Oral Suspension*40 mg* suspension in apple juice or applesauce only Each packet…

    Discoloration — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the USA.